181 related articles for article (PubMed ID: 36630482)
1. Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer.
Lastwika KJ; Kunihiro A; Solan JL; Zhang Y; Taverne LR; Shelley D; Rho JH; Randolph TW; Li CI; Grogan EL; Massion PP; Fitzpatrick AL; MacPherson D; Houghton AM; Lampe PD
Sci Transl Med; 2023 Jan; 15(678):eadd8469. PubMed ID: 36630482
[TBL] [Abstract][Full Text] [Related]
2. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.
Kazarian M; Laird-Offringa IA
Mol Cancer; 2011 Mar; 10():33. PubMed ID: 21450098
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
Zekeridou A; Majed M; Heliopoulos I; Lennon VA
Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
[TBL] [Abstract][Full Text] [Related]
4. CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer.
Kunihiro AG; Sarrett SM; Lastwika KJ; Solan JL; Pisarenko T; Keinänen O; Rodriguez C; Taverne LR; Fitzpatrick AL; Li CI; Houghton AM; Zeglis BM; Lampe PD
J Nucl Med; 2022 Nov; 63(11):1701-1707. PubMed ID: 35483965
[TBL] [Abstract][Full Text] [Related]
5. An Autoantibody Subset Can Be Used for SCLC Early Detection.
Cancer Discov; 2023 Mar; 13(3):526. PubMed ID: 36661372
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.
Cui T; Hurtig M; Elgue G; Li SC; Veronesi G; Essaghir A; Demoulin JB; Pelosi G; Alimohammadi M; Öberg K; Giandomenico V
PLoS One; 2010 Dec; 5(12):e16010. PubMed ID: 21209860
[TBL] [Abstract][Full Text] [Related]
7. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy.
Budde-Steffen C; Anderson NE; Rosenblum MK; Posner JB
Cancer Res; 1988 Jan; 48(2):430-4. PubMed ID: 2825975
[TBL] [Abstract][Full Text] [Related]
8. Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung.
Matsumoto T; Ryuge S; Kobayashi M; Kageyama T; Hattori M; Goshima N; Jiang SX; Saegusa M; Iyoda A; Satoh Y; Masuda N; Sato Y
Int J Oncol; 2012 Jun; 40(6):1957-62. PubMed ID: 22426972
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic neurological syndromes in patients affected by SCLC: a case series.
Zanella C; Leone AG; Zambelli L; Bottiglieri A; Canziani L; Brambilla M; Lo Russo G; Platania M; De Braud F; Occhipinti M
Tumori; 2022 Dec; 108(6):NP11-NP14. PubMed ID: 35260015
[TBL] [Abstract][Full Text] [Related]
10. The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.
Maddison P; Titulaer MJ; Verschuuren JJ; Gozzard P; Lang B; Irani SR; Sabater L; Graus F; Murray A; Chapman CJ
J Neuroimmunol; 2019 Jan; 326():14-18. PubMed ID: 30445363
[TBL] [Abstract][Full Text] [Related]
11. Initial screening for neuronal autoantibodies and their putative impact on survival in patients with small-cell lung cancer.
Mikkelsen AW; Nilsson AC; Tenstad HB; Lillevang ST; Asgari N
Thorac Cancer; 2024 May; ():. PubMed ID: 38703039
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer.
Anderson NE; Rosenblum MK; Graus F; Wiley RG; Posner JB
Neurology; 1988 Sep; 38(9):1391-8. PubMed ID: 2842702
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
[TBL] [Abstract][Full Text] [Related]
14. Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer.
Bartels F; Wandrey MM; Aigner A; Strönisch T; Farmer K; Rentzsch K; Tessmer A; Grohé C; Finke C
JAMA Oncol; 2021 Sep; 7(9):1302-1310. PubMed ID: 34196651
[TBL] [Abstract][Full Text] [Related]
15. Complicated paraneoplastic neurological syndromes: a report of two patients with small cell or non-small cell lung cancer.
Hiasa Y; Kunishige M; Mitsui T; Kondo S; Kuriwaka R; Shigekiyo S; Kanematsu T; Satake N; Bando Y; Kondo A; Endo I; Oshima Y; Matsumoto T
Clin Neurol Neurosurg; 2003 Dec; 106(1):47-9. PubMed ID: 14643918
[TBL] [Abstract][Full Text] [Related]
16. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
17. Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.
Ruiz-García R; Martínez-Hernández E; García-Ormaechea M; Español-Rego M; Sabater L; Querol L; Illa I; Dalmau J; Graus F
Front Immunol; 2019; 10():769. PubMed ID: 31031763
[TBL] [Abstract][Full Text] [Related]
18. Detection of tumor-specific autoantibodies in sera of patients with lung cancer.
Nagashio R; Sato Y; Jiang SX; Ryuge S; Kodera Y; Maeda T; Nakajima T
Lung Cancer; 2008 Dec; 62(3):364-73. PubMed ID: 18485524
[TBL] [Abstract][Full Text] [Related]
19. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.
Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L
Front Immunol; 2021; 12():728853. PubMed ID: 35140701
[TBL] [Abstract][Full Text] [Related]
20. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
